Safety and Efficacy of PC945 in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis

Condition:   Refractory IPA Interventions:   Drug: PC945;   Drug: Placebo Sponsor:   Pulmocide Ltd Not yet recruiting

Source: ClinicalTrials.gov - February 14, 2022 Category: Research Source Type: clinical trials